1h Free Analyst Time
The intravenous IV solutions market is forecast to grow by USD 4011.34 mn during 2022-2027, accelerating at a CAGR of 7.11% during the forecast period. The report on the intravenous iv solutions market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of chronic diseases, the growing geriatric population, and the increasing demand for parenteral nutrition.
The intravenous IV solutions market is segmented as below:
By Type
- Partial parenteral nutrition
- Total parenteral nutrition
By Distribution Channel
- Hospital pharmacy
- Retail pharmacy
- Online pharmacy
By Geographical Landscape
- Asia
- North America
- Europe
- Rest of World (ROW)
The report on the intravenous iv solutions market covers the following areas:
- Intravenous IV solutions market sizing
- Intravenous IV solutions market forecast
- Intravenous IV solutions market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by Distribution Channel
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global intravenous iv solutions market: Amanta Healthcare Ltd., Axa Parenterals Ltd., Baxter International Inc., Fresenius SE and Co. KGaA, Grifols SA, ICU Medical Inc., JW Pharmaceutical Corp., Lxir Medilabs Pvt. Ltd., MITS Healthcare Pvt. Ltd., Pfizer Inc., Salius Pharma Pvt. Ltd., Schwitz Biotech, Sichuan Kelun Pharmaceutical Co. Ltd., Soxa Formulations and Research Pvt. Ltd., Terumo Group, Vifor Pharma Management Ltd., Vikrant Life Sciences Pvt. Ltd., Vitapure Corp., B. Braun Melsungen AG, and Otsuka Holdings Co. Ltd..Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is technological advancements in IV solutions.'
According to the report, one of the major drivers for this market is the increasing prevalence of chronic diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Amanta Healthcare Ltd.
- Axa Parenterals Ltd.
- Baxter International Inc.
- Fresenius SE and Co. KGaA
- Grifols SA
- ICU Medical Inc.
- JW Pharmaceutical Corp.
- Lxir Medilabs Pvt. Ltd.
- MITS Healthcare Pvt. Ltd.
- Pfizer Inc.
- Salius Pharma Pvt. Ltd.
- Schwitz Biotech
- Sichuan Kelun Pharmaceutical Co. Ltd.
- Soxa Formulations and Research Pvt. Ltd.
- Terumo Group
- Vifor Pharma Management Ltd.
- Vikrant Life Sciences Pvt. Ltd.
- Vitapure Corp.
- B. Braun Melsungen AG
- Otsuka Holdings Co. Ltd.
